Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No data
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- not specified
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Diboron trioxide
- EC Number:
- 215-125-8
- EC Name:
- Diboron trioxide
- Cas Number:
- 1303-86-2
- Molecular formula:
- B2O3
- IUPAC Name:
- bicyclo[1.1.1]diboroxane
- Details on test material:
- - Name of test material: Diboron trioxide (anhydrous boric acid)
- Physical state: White powder
- Analytical purity: > 99 %
- Lot/batch No.: 5C183709
- Other: CHE dispensary No. 0604/95-1341
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD.BR
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate
- Age at study initiation: 5 - 8 weeks of age
- Weight at study initiation: 142 - 217 g
- Housing: Up to 5 rats were accommodated in suspended stainless steel mesh cages (dimensions 55 x 34 x 20 cm). The cages were suspended over carboard lined trays for collection of excreta. The liners were replaced at least twice weekly.
- Diet: Ad libitum except during fasting period
- Water: Ad libitum
- Fasting period before study: 18 h prior to dosing until 3 h after dosing
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25 C
- Humidity (%): 40 - 70 % relative humidity
- Air changes (per hr): at least 15
- Photoperiod (hrs dark / hrs light): 12 dark/light; typically 0600 to 1800 h.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle: 10 mL/kg
- Lot/batch no.: 1132
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg
DOSAGE PREPARATION: All formulations were used on the day of preparation. - Doses:
- 1540 and 2600 mg/kg
- No. of animals per sex per dose:
- 5 males per dose
- Control animals:
- no
- Details on study design:
- No data
- Statistics:
- No data
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 2 600 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: There were no deaths at this dose level.
- Mortality:
- No animal died following administration.
- Clinical signs:
- other: No clinical signs were observed for animals dosed at 1540 mg/kg. Piloerection was apparent from approximately 15 min after dosing and for the remainder of Day 1, for all 5 males dosed at 2600 mg/kg. Two rats were lethargic three hours after dosing and on
- Gross pathology:
- No macroscopic changes were observed during necropsy of Day 15 for animals at 2600 mg/kg.
Isolated changes seen in two rats dosed at 1540 mg/kg included a few red foci on the thymus (animals no 677) and pale lungs and distension of the jejunum (animal No. 678). - Other findings:
- No data
Any other information on results incl. tables
Clinical signs following treatment at dose level 2600 mg/kg:
Clinical sign |
Animal No. |
Time of first observation |
Time of recovery |
||||
675 M |
658 M |
659 M |
660 M |
661 M |
|||
Pilo-erection |
+ |
+ |
+ |
+ |
+ |
0.25 h |
Day 2 |
Lethargy |
- |
+ |
- |
+ |
- |
3 h |
Day 2 |
Tachypnoea |
- |
+ |
- |
- |
- |
3 h |
Day 2 |
+/- = sign present or absent
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- A single oral administration of anhydrous boric acid to groups of five fasted rats at dose levels of 1540 or 2600 mg/kg resulted in no deaths. The acute median lethal oral dose was therefore considered to be greater than 2000 mg/kg bw.
Based on the results of this study, the general Classification and Labelling Requirements as stated in EC No 1272/2008, indicate that no classification is required for anhydrous boric acid in respect of its acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.